Page last updated: 2024-11-04

temozolomide and Headache

temozolomide has been researched along with Headache in 11 studies

Headache: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.

Research Excerpts

ExcerptRelevanceReference
"Temozolomide (200 mg/m2 oral administration) was given to 12 patients with metastatic malignant melanoma."9.11Temozolomide pharmacodynamics in patients with metastatic melanoma: dna damage and activity of repair enzymes O6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1. ( Boddy, AV; Calvert, AH; Curtin, NJ; Harris, AL; Hickson, I; Jones, C; Margison, GP; McGown, G; McHugh, P; Middleton, MR; Newell, DR; Olsen, A; Plummer, ER; Thorncroft, M; Watson, AJ, 2005)
"Temozolomide (200 mg/m2 oral administration) was given to 12 patients with metastatic malignant melanoma."5.11Temozolomide pharmacodynamics in patients with metastatic melanoma: dna damage and activity of repair enzymes O6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1. ( Boddy, AV; Calvert, AH; Curtin, NJ; Harris, AL; Hickson, I; Jones, C; Margison, GP; McGown, G; McHugh, P; Middleton, MR; Newell, DR; Olsen, A; Plummer, ER; Thorncroft, M; Watson, AJ, 2005)
" The observed adverse effects of temozolomide included nausea, vomiting, headache, constipation, mild marrow suppression, and decreased activity; none of them was severe enough to discontinue the treatment."3.75Efficacy of temozolomide for recurrent embryonal brain tumors in children. ( Chang, KP; Hsu, TR; Wang, CH; Wong, TT, 2009)
"Ratio of log-transformed means (intravenous:oral) of area under the concentration-time curve and maximum concentration of drug after dosing for temozolomide and 5-(3-methyltriazen-1-yl)imidazole-4-carboxamide (MTIC) met exposure equivalence criteria (90% confidence interval = 0."2.75Evaluation of the exposure equivalence of oral versus intravenous temozolomide. ( Abutarif, MA; Cantillon, M; Cutler, D; Diez, BD; Kantesaria, B; Ottaviano, FH; Pallotta, MG; Schwarz, M; Statkevich, P; Xuan, F; Zhu, Y, 2010)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (45.45)29.6817
2010's4 (36.36)24.3611
2020's2 (18.18)2.80

Authors

AuthorsStudies
Li, F1
Zhang, Y1
Wang, N1
Song, C1
Gao, Y1
Diao, X1
Zhang, H1
Sarper, B1
Yaprak Bayrak, B1
Halis, H1
Alparslan, B1
Yeni Bayraktar, H1
Bilbao, I1
Egaña, N1
García, C1
Olaizola, I1
Yeo, KK1
Puscasiu, E1
Keating, RF1
Rood, BR1
Zakaria, Z1
Fenton, E1
Khalil, A1
Sattar, MT1
Molnar, P1
Wang, CH1
Hsu, TR1
Wong, TT1
Chang, KP1
Diez, BD1
Statkevich, P1
Zhu, Y1
Abutarif, MA1
Xuan, F1
Kantesaria, B1
Cutler, D1
Cantillon, M1
Schwarz, M1
Pallotta, MG1
Ottaviano, FH1
Rojas-Marcos, I1
Calvet, D1
Janoray, P1
Delattre, JY1
Harkness, KA1
Manford, MR1
Plummer, ER1
Middleton, MR1
Jones, C1
Olsen, A1
Hickson, I1
McHugh, P1
Margison, GP1
McGown, G1
Thorncroft, M1
Watson, AJ1
Boddy, AV1
Calvert, AH1
Harris, AL1
Newell, DR1
Curtin, NJ1
Steckley, JL1
Watling, CJ1
Ng, W1

Trials

2 trials available for temozolomide and Headache

ArticleYear
Evaluation of the exposure equivalence of oral versus intravenous temozolomide.
    Cancer chemotherapy and pharmacology, 2010, Volume: 65, Issue:4

    Topics: Administration, Oral; Adult; Anemia; Antineoplastic Agents, Alkylating; Area Under Curve; Central Ne

2010
Temozolomide pharmacodynamics in patients with metastatic melanoma: dna damage and activity of repair enzymes O6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, May-01, Volume: 11, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Comet Assay; Dacarbazine; DNA Dam

2005

Other Studies

9 other studies available for temozolomide and Headache

ArticleYear
Evaluation of the Prognosis of Neuroglioma Based on Dynamic Magnetic Resonance Enhancement.
    World neurosurgery, 2020, Volume: 138

    Topics: Antineoplastic Agents, Alkylating; Brain Edema; Brain Neoplasms; Chemotherapy, Adjuvant; Contrast Me

2020
Malignant Astroblastoma
    Balkan medical journal, 2020, 06-01, Volume: 37, Issue:4

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Immunological; Bevacizumab; Headache; Huma

2020
Failure of a second temozolomide cycle in a patient with a prolactin-secreting pituitary carcinoma.
    Endocrinologia, diabetes y nutricion, 2017, Volume: 64, Issue:10

    Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bromocriptine; Cabergoline; Combined

2017
Durable response of intracranial cellular hemangioma to bevacizumab and temozolomide.
    Journal of neurosurgery. Pediatrics, 2013, Volume: 11, Issue:6

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brai

2013
Stupp-treated glioblastoma accompanied by EBV-positive primary CNS lymphoma.
    British journal of neurosurgery, 2014, Volume: 28, Issue:2

    Topics: Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Clinical Protocols; Dac

2014
Efficacy of temozolomide for recurrent embryonal brain tumors in children.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2009, Volume: 25, Issue:5

    Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; D

2009
Response of recurrent anaplastic ependymoma to a combination of tamoxifen and isotretinoin.
    Neurology, 2003, Oct-14, Volume: 61, Issue:7

    Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplas

2003
Metastatic malignant melanoma presenting as a cavernous sinus syndrome.
    Journal of neurology, 2004, Volume: 251, Issue:2

    Topics: Adult; Antineoplastic Agents; Biomarkers, Tumor; Blepharoptosis; Cavernous Sinus Thrombosis; Cranial

2004
Glioblastoma in a patient with a hereditary cancer syndrome.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2008, Volume: 35, Issue:1

    Topics: Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cerebral Hemorrhage; Colorectal Neoplasms;

2008